Delivery luteolin with folacin-modified nanoparticle for glioma therapy

Cong Wu, Qian Xu, Xinyue Chen, Jiagang Liu Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaCorrespondence: Jiagang LiuDepartment of Neurosurgery, West China Hospital, West China Medical School, Sichua...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wu C, Xu Q, Chen X, Liu J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/446dd61f16fb4a43b6a4c78705d1b1ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:446dd61f16fb4a43b6a4c78705d1b1ff
record_format dspace
spelling oai:doaj.org-article:446dd61f16fb4a43b6a4c78705d1b1ff2021-12-02T04:45:09ZDelivery luteolin with folacin-modified nanoparticle for glioma therapy1178-2013https://doaj.org/article/446dd61f16fb4a43b6a4c78705d1b1ff2019-09-01T00:00:00Zhttps://www.dovepress.com/delivery-luteolin-with-folacin-modified-nanoparticle-for-glioma-therap-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Cong Wu, Qian Xu, Xinyue Chen, Jiagang Liu Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaCorrespondence: Jiagang LiuDepartment of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaTel +86 288 542 2136Fax +86 288 550 2796Email jiagang_liu@163.comBackground: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability.Patients and methods: In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo.Results: When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL.Conclusion: These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention.Keywords: luteolin, PEG-PCL, glioma, folic acid, apoptosisWu CXu QChen XLiu JDove Medical PressarticleLuteolinPEG-PCLgliomafolic acidapoptosis.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7515-7531 (2019)
institution DOAJ
collection DOAJ
language EN
topic Luteolin
PEG-PCL
glioma
folic acid
apoptosis.
Medicine (General)
R5-920
spellingShingle Luteolin
PEG-PCL
glioma
folic acid
apoptosis.
Medicine (General)
R5-920
Wu C
Xu Q
Chen X
Liu J
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
description Cong Wu, Qian Xu, Xinyue Chen, Jiagang Liu Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaCorrespondence: Jiagang LiuDepartment of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People’s Republic of ChinaTel +86 288 542 2136Fax +86 288 550 2796Email jiagang_liu@163.comBackground: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability.Patients and methods: In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo.Results: When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL.Conclusion: These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention.Keywords: luteolin, PEG-PCL, glioma, folic acid, apoptosis
format article
author Wu C
Xu Q
Chen X
Liu J
author_facet Wu C
Xu Q
Chen X
Liu J
author_sort Wu C
title Delivery luteolin with folacin-modified nanoparticle for glioma therapy
title_short Delivery luteolin with folacin-modified nanoparticle for glioma therapy
title_full Delivery luteolin with folacin-modified nanoparticle for glioma therapy
title_fullStr Delivery luteolin with folacin-modified nanoparticle for glioma therapy
title_full_unstemmed Delivery luteolin with folacin-modified nanoparticle for glioma therapy
title_sort delivery luteolin with folacin-modified nanoparticle for glioma therapy
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/446dd61f16fb4a43b6a4c78705d1b1ff
work_keys_str_mv AT wuc deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy
AT xuq deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy
AT chenx deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy
AT liuj deliveryluteolinwithfolacinmodifiednanoparticleforgliomatherapy
_version_ 1718401080926142464